Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Small Lymphocytic Leukemia (SLL)”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00625729
What this trial is testing

Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 6
Testing effectiveness (Phase 2)Study completedNCT02208037
What this trial is testing

Novel Approaches for Graft-versus-Host Disease Prevention Compared to Contemporary Controls (BMT CTN 1203)

Who this might be right for
Acute LeukemiaChronic Myelogenous LeukemiaMyelodysplasia+6 more
National Heart, Lung, and Blood Institute (NHLBI) 279
Not applicableUnknownNCT01862445
What this trial is testing

Retrospective Study: Efficacy and Safety of Chlorambucil + Rituximab in CLL Patients

Who this might be right for
CLLB-cellSmall Lymphocytic Lymphoma+2 more
Gruppo Italiano Malattie EMatologiche dell'Adulto 100
Testing effectiveness (Phase 2)Looking for participantsNCT06849713
What this trial is testing

Zanubrutinib, Obinutuzumab, Sonrotoclax (BOSon) or BGB-16673, Obinutuzumab, Sonrotoclax (DOSon) in TN CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma (SLL)
Massachusetts General Hospital 80
Large-scale testing (Phase 3)UnknownNCT04578613
What this trial is testing

ICP-022 Versus Chlorambucil Combined With Rituximab in the Treatment of Untreated CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Beijing InnoCare Pharma Tech Co., Ltd. 218
Testing effectiveness (Phase 2)Ended earlyNCT01253460
What this trial is testing

Sapacitabine, Cyclophosphamide, Rituximab for Relapsed Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma (CLL/SLL) With Deletion (11q22-23)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 18
Early research (Phase 1)Study completedNCT01832922
What this trial is testing

BR in Patients With CLL With Comorbidities and/or Renal Dysfunction

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Dartmouth-Hitchcock Medical Center 8
Testing effectiveness (Phase 2)Study completedNCT00275431
What this trial is testing

Phase II Safety and Efficacy Study of Single-agent AT-101 in Patients With Relapsed or Refractory B-cell Malignancies

Who this might be right for
Follicular LymphomaDiffuse Large Cell LymphomaMantle Cell Lymphoma+2 more
Ascenta Therapeutics 50
Not applicableLooking for participantsNCT05876923
What this trial is testing

The Effects of Exercise on Immune Phenotype of Indolent Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia Patients

Who this might be right for
Chronic Lymphocytic Leukemia/Small Lymphocytic LymphomaIndolent Non-hodgkin Lymphoma
Mayo Clinic 70
Early research (Phase 1)Study completedNCT00019656
What this trial is testing

Perifosine in Treating Patients With Refractory Solid Tumors or Hematologic Cancer

Who this might be right for
LeukemiaLymphomaMyelodysplastic Syndromes+2 more
National Cancer Institute (NCI)
Early research (Phase 1)Study completedNCT01212380
What this trial is testing

Study of Carfilzomib in Chronic Lymphocytic Leukemia (CLL), Small Lymphocytic Lymphoma (SLL) or Prolymphocytic Leukemia (PLL)

Who this might be right for
B-cell Chronic Lymphocytic LeukemiaHematopoietic/Lymphoid CancerProlymphocytic Leukemia+2 more
Ohio State University Comprehensive Cancer Center 21
Testing effectiveness (Phase 2)Study completedNCT02406742
What this trial is testing

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Who this might be right for
Leukemia, Lymphocytic, Chronic, B-Cell
Celgene 47
Testing effectiveness (Phase 2)Active Not RecruitingNCT07162181
What this trial is testing

Long-Term Safety of Pirtobrutinib in Participants With Previously Treated Types of Blood Cancers

Who this might be right for
Lymphoma, Non-HodgkinLeukemia, Lymphocytic, Chronic, B-CellB-cell Lymphoma
Eli Lilly and Company 13
Large-scale testing (Phase 3)Looking for participantsNCT07321652
What this trial is testing

Testing the Addition of Anti-Cancer Drug Sonrotoclax, to the Standard Treatment Zanubrutinib, for Previously Untreated CLL/SLL

Who this might be right for
Chronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia
Alliance for Clinical Trials in Oncology 466
Early research (Phase 1)Study completedNCT00244946
What this trial is testing

Combination Chemotherapy Followed By Autologous Stem Cell Transplant, and White Blood Cell Infusions in Treating Patients With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
Barbara Ann Karmanos Cancer Institute 15
Early research (Phase 1)Ended earlyNCT03878524
What this trial is testing

Serial Measurements of Molecular and Architectural Responses to Therapy (SMMART) PRIME Trial

Who this might be right for
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 PositiveAnatomic Stage IV Breast Cancer AJCC v8Anemia+47 more
OHSU Knight Cancer Institute 2
Testing effectiveness (Phase 2)Active Not RecruitingNCT04419519
What this trial is testing

Assessing Minimal Residual Disease by Next- Generation Sequencing to Minimize Exposure in People With CLL or SLL Who Have Been Treated With Venetoclax

Who this might be right for
Chronic Lymphocytic Leukemia (CLL)Small Lymphocytic Lymphoma (SLL)
Memorial Sloan Kettering Cancer Center 81
Early research (Phase 1)Study completedNCT00002765
What this trial is testing

Immunotoxin in Treating Patients With Leukemia or Lymphoma

Who this might be right for
LeukemiaLymphoma
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00003245
What this trial is testing

Irinotecan in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Looking for participantsNCT05702853
What this trial is testing

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed/Refractory NHL, CLL/SLL

Who this might be right for
B-cell Non Hodgkin LymphomaChronic Lymphocytic Leukemia
Medical University of South Carolina 27
Next Page